Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 431 of 5804
-
New combo therapy targets gut disease and obesity together
Disease control Recruiting nowThe main purpose of this study is to show whether in these individuals, treatment with both mirikizumab and tirzepatide, compared with treatment with mirikizumab and placebo, leads to decrease or disappearance of UC symptoms, and loss of at least one-tenth of the overall body wei…
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Fewer radiation sessions could boost cervical cancer fight
Disease control Recruiting nowThe goal of this clinical trial is to investigate the use of hypofractionated radiation (delivery of fewer but larger doses of radiation) with concurrent chemotherapy for women with metastatic of bulky uterine cervix cancer. The main questions it aims to answer are: * What is th…
Phase: PHASE2 • Sponsor: Denise Fabian • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New hope for DM1: Long-Term trial of AOC 1001 underway
Disease control ENROLLING_BY_INVITATIONA Global Phase 3 Open-Label Extension Study to Assess the Long-Term Safety, Tolerability, and Efficacy of Intravenous Delpacibart Etedesiran (abbreviated del-desiran, formerly AOC 1001) for the Treatment of Myotonic Dystrophy Type 1
Phase: PHASE3 • Sponsor: Avidity Biosciences, Inc. • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Can a Weight-Loss drug boost Crohn's treatment? new trial aims to find out
Disease control Recruiting nowThe main purpose of this study is to evaluate the efficacy and safety of mirikizumab and placebo compared with mirikizumab and concomitantly administered tirzepatide in adult participants with moderately to severely active CD and obesity, or overweight. The maximum duration of t…
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Five-Minute Finger-Prick test could speed syphilis diagnosis in pregnancy
Diagnosis Recruiting nowThe goal of this clinical trial is to learn if a finger-prick blood test for rapid diagnosis of syphilis infection can be implemented in a low-barrier prenatal clinic for people at risk of syphilis in pregnancy. The test gives results in 5 minutes and also tests for HIV. The mai…
Phase: NA • Sponsor: McMaster University • Aim: Diagnosis
Last updated Jul 09, 2026 00:00 UTC
-
New shot could replace pills to prevent clots after knee surgery
Disease control Recruiting nowThis study is researching an experimental drug called REGN7508 (called "study drug"). The study is focused on adults undergoing elective, unilateral (one side) total knee replacement surgery. The aim of the study is to see how effective the study drug is at preventing Venous Thr…
Phase: PHASE3 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Can an EV71 vaccine protect older kids too?
⭐️ VACCINE ⭐️ OngoingThe purpose of this study is to assess the immunogenicity and safety of EV71 vaccine (Envacgen®) in Children Aged 6 to \<10 Years compared to Children Aged 2 to \<6 Years.
Phase: PHASE3 • Sponsor: Medigen Vaccine Biologics Corp. • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:29 UTC
-
New drug combo aims to control advanced breast cancer
Disease control Recruiting nowThis study is a prospective, open-label, randomized, multicenter, two-cohort phase II clinical trial. Starting from December 1, 2024, it plans to enroll 120 patients with advanced first-line HR-positive, HER2-negative breast cancer. A centralized randomization system (IWRS) will …
Phase: PHASE2 • Sponsor: wanghaibo • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Virus therapy takes on Hard-to-Treat lung cancer brain spread
Disease control Recruiting nowPhase Ib/II clinical study on evaluating the safety, tolerance, biodistribution characteristics and preliminary efficacy of recombinant human nsIL12 oncolytic adenovirus injection (BioTT001) in the treatment of meningeal metastasis in recurrent/progressive non-small cell lung can…
Phase: PHASE1, PHASE2 • Sponsor: Henan Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Can your own belly fat fix your aching knee?
Disease control OngoingThis randomized, controlled clinical trial will evaluate the safety and effectiveness of autologous adipose-derived stromal vascular fraction (SVF) therapy in patients with knee osteoarthritis (OA) grades II-IV, compared with standard chondroprotective (CP) treatment. The study w…
Phase: PHASE4 • Sponsor: Clinical Center of Vojvodina • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New drug combo aims to shrink ovarian tumors before surgery, no chemo needed
Disease control Recruiting nowIn this study, investigators propose to use fuzuloparib and apatinib as neoadjuvant therapy for Homologous recombination deficiency (HRD)positive advanced ovarian cancer patients, aiming to explore the efficacy and safety of this 'de-chemotherapy' regimen as neoadjuvant therapy f…
Phase: PHASE2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New vaccine combo takes on tough cancers
Disease control Recruiting nowPhase 1b study evaluating the efficacy and immune response to a synthetic long peptide mutant KRAS vaccine (SPL mKRASvax) combined with Balstilimab and Botensilimab for unresectable or metastatic mismatch repair-proficient (MMR-p) colorectal cancer (mCRC) or unresectable or metas…
Phase: PHASE1 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Could a Three-Drug combo beat back recurrent breast cancer?
Disease control Recruiting now* Breast cancer is histologically divided into non-invasive (approximately 10%) and invasive (approximately 90%), with invasive cancer being the target of chemotherapy. Invasive carcinoma is classified into four subtypes according to the expression levels of hormone receptor (HR)…
Phase: PHASE2 • Sponsor: Yukinori Ozaki • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Peanut patch for toddlers: could a sticker ease allergy fears?
Disease control OngoingThe primary objective of this study is to assess the 6-month safety of DBV712 250 micrograms (mcg) in subjects 1 through 3 years of age with peanut allergy.
Phase: PHASE3 • Sponsor: DBV Technologies • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New drug duo offers hope for hard-to-treat vulvar cancer
Disease control Recruiting nowEvaluation of efficacy and safety of pembrolizumab in combination with lenvatinib in patients with recurrent, persistent, metastatic or locally advanced vulva cancer.
Phase: PHASE2 • Sponsor: AGO Research GmbH • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New hope for Hard-to-Treat nasopharyngeal cancer: four drug cocktails enter trial
Disease control Recruiting nowThis is a prospective, Bayesian adaptive, phase II clinical trial designed to evaluate the safety and efficacy of four treatment regimens in patients with recurrent (unamenable to local therapy) or metastatic nasopharyngeal carcinoma (NPC) who have failed after at least one prior…
Phase: PHASE2 • Sponsor: Ming-Yuan Chen • Aim: Disease control
Last updated Jun 26, 2026 18:42 UTC
-
New study aims to help pregnant women with opioid addiction get better care and keep families together
Disease control ENROLLING_BY_INVITATIONThe investigators seek to adapt a collaborative care model (CCM) for community-based, low-resource obstetric settings and to test the effects of this adapted CCM on health outcomes among Pregnant, postpartum, and parenting person (PPPP) with Opioid use disorder (OUD) and their fa…
Sponsor: University of Pittsburgh • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New combo therapy shows promise for aggressive lung cancer in japanese patients
Disease control OngoingEvaluate Clinical Efficacy, Safety and Pharmacokinetics of HLX10 (Recombinant Humanized Anti-PD-1 Monoclonal Antibody Injection) in Combination with Chemotherapy (Carboplatin-Etoposide) in Previously Untreated Japanese Patients with Extensive Stage Small Cell Lung Cancer (ES-SCLC…
Phase: PHASE2 • Sponsor: Shanghai Henlius Biotech • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Landmark study questions blood thinner use in Behçet's clots
Disease control Recruiting nowIn patients with Behçet's syndrome (BS), deep venous thrombosis (DVT) is thought to result from inflammation of the vessel wall rather than hyper coagulability. Post Thrombotic Syndrome (PTS) is frequent especially with recurrent episodes of deep vein thrombosis and may result i…
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New pill targets hard-to-treat cancers with KRAS G12D mutation
Disease control Recruiting nowThis study will assess the safety and efficacy of VS-7375 alone and in combination in patients with advanced solid tumors harboring a KRAS G12D-mutation.
Phase: PHASE1, PHASE2 • Sponsor: Verastem, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC